A frequent reason for discontinuation of therapy is dry mouth, which is reported by as many as 80% of patients receiving the immediate-release formulation of oxybutynin (widely considered the ...

Request To Download Free Sample of This Strategic Report @- The Global Xerostomia Therapeutics Market is poised for significant growth, with an anticipated reach of over USD 822.14 million by 2026, ...

A dry mouth, or xerostomia, is a common condition that affects up to 10million people in the UK. It is most prevalent among older people and those who have had cancer treatment or need to take a mix ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

A dentist has shared a common and persistent issue many people regularly deal with could actually be a symptom of mouth cancer - and it's something that needs prompt treatment to stand a decent chance ...

A recent study showed that mouth taping, as mimicked by closing the mouth in people with sleep apnea, may not be the cure-all ...